Beijing, China

Zhenhe Wang


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,718 
Other
 patents

Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Zhenhe Wang

Introduction

Zhenhe Wang is a notable inventor based in Beijing, China. He has made significant contributions to the pharmaceutical field, particularly in the area of tumor prevention and treatment. His innovative work has the potential to impact cancer therapies and improve patient outcomes.

Latest Patents

Zhenhe Wang holds a patent for a tumor prevention and treatment drug, specifically focusing on the use of 8-oxo-deoxyguanosine triphosphate (8-oxo-dGTP). This invention discloses a medicament designed for the prevention and treatment of tumors. The patent highlights the significant inhibitory effect of 8-oxo-dGTP on tumorigenesis and tumor cell proliferation across various types of tumors. Animal experiments have demonstrated that 8-oxo-dGTP is significantly more effective than 5-FU in tumor inhibition, showcasing its industrial availability and substantial business and social value.

Career Highlights

Throughout his career, Zhenhe Wang has been involved in groundbreaking research and development in the pharmaceutical industry. His work on 8-oxo-dGTP positions him as a key figure in the fight against cancer, contributing to the advancement of effective treatment options.

Collaborations

Zhenhe Wang has collaborated with notable individuals in his field, including Jianping Cai and Jin Li. These partnerships have likely enhanced the scope and impact of his research efforts.

Conclusion

Zhenhe Wang's innovative contributions to tumor prevention and treatment exemplify the importance of research in the pharmaceutical field. His patent for 8-oxo-dGTP represents a promising advancement in cancer therapy, with the potential to improve the lives of many patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…